Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment

By LabMedica International staff writers
Posted on 20 Oct 2025

Cardiovascular diseases remain the leading cause of death worldwide, and while artificial intelligence (AI) has shown promise in their diagnosis and management, most existing systems rely on a single data type such as ECGs or cardiac imaging. More...

This limits diagnostic accuracy and prevents algorithms from reflecting the comprehensive reasoning process that physicians use in clinical practice. Now, a new multimodal AI approach aims to overcome this limitation by integrating diverse clinical data sources to deliver more accurate and personalized cardiovascular insights.

The study, led by West China Hospital of Sichuan University (Sichuan, China) and the University of Copenhagen (Copenhagen, Denmark), reviewed over 150 studies demonstrating the potential of multimodal AI in cardiovascular medicine. This next-generation approach fuses complementary data modalities—such as echocardiography, computed tomography, magnetic resonance imaging, and genomics—to enhance diagnostic precision. For example, a transformer-based neural network combining chest radiographs with clinical variables simultaneously identified 25 critical pathologies in intensive-care patients, achieving an average diagnostic accuracy (AUC) of 0.77.

The review, published in Precision Clinical Medicine, showed that multimodal AI can also reveal new biological insights. By integrating cardiac MRI with genome-wide association data, researchers identified novel genetic loci linked to aortic valve function. In addition to diagnosis, these models refined treatment decisions—predicting which heart-failure patients would respond to cardiac resynchronization therapy and identifying those unlikely to benefit from mitral-valve repair, thereby improving patient selection and treatment efficiency.

Emerging multimodal algorithms also enable continuous health monitoring by merging data from wearable devices, mobile applications, and electronic health records. These tools can detect early signs of deterioration, deliver automated health coaching, and reduce readmission rates. The authors estimate that adopting multimodal AI in clinical practice could reduce cardiovascular healthcare costs by 5%−10% over five years through improved efficiency and fewer complications.


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.